BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16335905)

  • 21. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
    Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
    Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
    Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
    Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
    Dunne C; Havelock JC
    J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
    Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian hilus-cell tumours: their varying presentations.
    Salm R
    J Pathol; 1974 Jun; 113(2):117-27. PubMed ID: 4371065
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
    Souto SB; Baptista PV; Braga DC; Carvalho D
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virilization persists in a woman with an androgen-secreting granulosa cell tumor.
    Patel SS; Carrick KS; Carr BR
    Fertil Steril; 2009 Mar; 91(3):933.e13-5. PubMed ID: 19062005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
    Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
    Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian Leydig Cell Tumor Associated with Recurrent Torsion and Virilization in an Adolescent Patient.
    Roth L; Smith AK; Buza N; Coons B; Stitelman D; Vash-Margita A
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):217-219. PubMed ID: 38110028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
    Yetkin DO; Demirsoy ET; Kadioglu P
    Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Virilizing ovarian tumor in an adolescent].
    François Y; Berlier P; Chatelain P; François R
    Pediatrie; 1990; 45(2):105-7. PubMed ID: 2158055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case report on the differential diagnosis of hyperandrogenism: adrenal or ovarian origin?].
    Saeger W
    Pathologe; 1988 Nov; 9(6):345-50. PubMed ID: 3237638
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
    Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
    Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
    Palha A; Cortez L; Tavares AP; Agapito A
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virilization with diffuse involvement of ovarian androgen secreting cells.
    Katz M; Hamilton SM; Albertyn L; Pimstone BL; Cohen BL; Tiltman AJ
    Obstet Gynecol; 1977 Nov; 50(5):623-7. PubMed ID: 909673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV; Loughlin J; Shapiro SS
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selective venous catheterization in the evaluation of androgenism].
    Urdl W; Lammer H; Tscherne G; Pickel H
    Wien Klin Wochenschr; 1986 May; 98(11):357-61. PubMed ID: 2941921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Virilizing ovarian tumor: a rare cause of androgenetic alopecia].
    Bahloul E; Amouri M; Masmoudi A; Chaabene K; Mnif F; Makni S; Amouri H; Abid M; Boudawara T; Turki H
    Ann Dermatol Venereol; 2015 Apr; 142(4):303-4. PubMed ID: 25813185
    [No Abstract]   [Full Text] [Related]  

  • 39. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
    Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
    Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of Leydig cell virilizing tumor of the ovary].
    Simonetti C; Di Vagno G; Cazzolla A; Melilli G; Di Gesú G; Cormio G; Selvaggi L
    Minerva Ginecol; 1998 Dec; 50(12):545-7. PubMed ID: 10069169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.